-
Influence and Mechanism of Lung Cavitation Development on Antiangiogenic Therapy
Is development of lung cavitation following apatinib therapy for lung cancer associated with better outcomes?
November 06, 2019
-
Treatment Modes for EGFR Mutations in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Medical oncologists and radiation oncologists often disagree about management of brain metastases associated with EGFR+ NSCLC. These authors think "interdisciplinary collaboration" is needed.
October 22, 2019
-
Prognostic Role of Pretreatment Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy
Is an elevated neutrophil-to-lymphocyte ratio prior to receiving chemotherapy, immunotherapy, or targeted therapy associated with inferior survival in patients with NSCLC ?
September 27, 2019
-
Molecular Testing Strategies in Non-Small Cell Lung Cancer
These 'real world' tactics for molecular testing in patients with a new diagnosis of advanced NSCLC will help clinicians determine optimal first-line targeted therapy.
August 29, 2019
-
TNM Stages Inversely Correlate With The Age at Diagnosis in ALK-Positive Lung Cancer
Younger adults are more likely to be diagnosed with T3/4 stage ALK-positive lung cancer than older adults.
July 29, 2019
-
Lung Cancer Screening and Shared Decision Making in Cancer Survivors
Little is known about the effectiveness of lung cancer screening in cancer survivors, a group with very diverse characteristics. How should clinicians frame shared decision making discussions?
June 28, 2019
-
Combining Stereotactic Body Radiation Therapy With Immunotherapy
Learn about ongoing clinical trials and the potential for clinical synergy between radiation and immunotherapy.
May 29, 2019
-
Empiric Radiotherapy for Lung Cancer Collaborative Group Multiinstitutional Evidence-Based Guidelines for the Use of Empiric Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Without Pathologic Confirmation
What is the overall efficacy of stereotactic body radiation therapy for patients with early stage NSCLC when biopsy confirmation is too high-risk?
April 29, 2019
-
Predictive Markers for Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung Cancer
What is the current outlook for using predictive markers to guide treatment for patients with NSCLC? What challenges face laboratories implementing these tests?
March 29, 2019
-
Measuring Tumor Mutation Burden in Non-Small Cell Lung Cancer
Tumor mutation burden may be a promising tool to guide immunotherapy, yet many questions need to be answered before adoption into clinical practice.
February 28, 2019
-
Combined Modality Treatment in Mesothelioma
Is combined modality treatment using surgery, radiotherapy and/or chemotherapy improving outcomes in malignant mesothelioma?
January 30, 2019
-
Current Chemotherapy Strategies in Malignant Pleural Mesothelioma
Is immunotherapy beneficial in patients with progressive malignant pleural mesothelioma after initial platinum-based chemotherapy?
December 31, 2018
-
Inherited Lung Cancer Syndromes Targeting Never Smokers
Which germline mutations are associated with inherited lung cancer syndromes in never smokers?
November 30, 2018
-
Ground-Glass Nodules of the Lung in Never-Smokers and Smokers
How long should ground glass nodules of the lung be monitored and what are predictors of their growth?
October 31, 2018
-
Appropriate Screening Intervals in Low-Dose CT Lung Cancer Screening
In which patients may a prolonged lung cancer screening interval be used?
September 03, 2018
-
Selecting Lung Cancer Screenees Using Risk Prediction Models
Several trials are evaluating whether risk can be used to to determine eligibility for lung cancer screening.
August 03, 2018
-
Particle Therapy in Non-Small Cell Lung Cancer
What is the latest evidence on proton therapy for locally advanced lung cancer?
June 25, 2018
-
Proton Beam Therapy and Immunotherapy
Are outcomes improved in patients with NSCLC receiving both proton beam therapy and immunotherapy?
May 25, 2018
-
Targeting DNA Damage Repair in Small Cell Lung Cancer and the Biomarker Landscape
Areas of investigation for SCLC include identification of predictive biomarkers, effective combinations to overcome resistance, and strategies for immunotherapy.
April 16, 2018
-
Current Standards for Clinical Management of Small Cell Lung Cancer
Review the latest on diagnosis, staging, and management of SCLC.
March 15, 2018
